The role of CD44 in the assessment of minimal residual disease of multiple myeloma by flow cytometry.

MLA

Zuo, Xiaojia, et al. “The Role of CD44 in the Assessment of Minimal Residual Disease of Multiple Myeloma by Flow Cytometry.” Journal of Hematopathology, vol. 14, no. 4, Dec. 2021, pp. 299–307. EBSCOhost, https://doi.org/10.1007/s12308-021-00468-2.

APA

Zuo, X., Feng, J., Ye, L., Xing, M., Deng, Z., Gu, X., & Liu, D. (2021). The role of CD44 in the assessment of minimal residual disease of multiple myeloma by flow cytometry. Journal of Hematopathology, 14(4), 299–307. https://doi.org/10.1007/s12308-021-00468-2

Chicago

Zuo, Xiaojia, Jinyi Feng, Lilin Ye, Miao Xing, Zhikui Deng, Xuefeng Gu, and Dingsheng Liu. 2021. “The Role of CD44 in the Assessment of Minimal Residual Disease of Multiple Myeloma by Flow Cytometry.” Journal of Hematopathology 14 (4): 299–307. doi:10.1007/s12308-021-00468-2.